Literature DB >> 5463574

Titration of cholera antitoxin in human sera by microhemagglutination with formalinized erythrocytes.

H D Hochstein, J C Feeley, W E DeWitt.   

Abstract

Microtiter hemagglutination tests employing formalinized sheep erythrocytes sensitized with either crude or purified cholera toxin were used to assay the cholera antitoxin content of human sera. Comparable results were obtained with either crude or purified toxin-sensitized cells with the exception of two sera that gave unusually high hemagglutination titers with the crude toxin. Sera from 13 convalescent cholera patients showed a high degree of correlation between antitoxin levels as determined in vitro by the hemagglutination test and in vivo by the skin permeability factor neutralization test. Fourfold or greater rises in antitoxin levels between acute and convalescent sera were detected in 9 of 15 patients with bacteriologically proven cholera. No significant increases in titer were observed in 14 cases of noncholera diarrhea. Cholera antitoxin was detected by hemagglutination in only 1 of 33 sera, obtained from eight countries, containing vibriocidal antibodies. Formalinized sheep erythrocytes sensitized with toxin and stored at 4 C in the presence of 1:10,000 thimerosal were stable and sensitive for at least 6 months (the longest time tested).

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5463574      PMCID: PMC376780          DOI: 10.1128/am.19.5.742-745.1970

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  10 in total

1.  PASSIVE SERUM PROTECTION OF THE INFANT RABBIT AGAINST EXPERIMENTAL CHOLERA.

Authors:  O R MCINTYRE; J C FEELEY
Journal:  J Infect Dis       Date:  1964-12       Impact factor: 5.226

2.  Preparation of formalinized erythrocytes.

Authors:  L CSIZMAS
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

3.  Titration of antibody to soluble antigens of the cholera vibrios by passive haemagglutination.

Authors:  A K Ghosh; G J Kasai; W Burrows
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

4.  Serological evidence for the identity of the vascular permeability factor and ileal loop toxin of Vibrio cholerae.

Authors:  W H Mosley; K M Aziz
Journal:  J Infect Dis       Date:  1970-03       Impact factor: 5.226

5.  Titration of cholera antitoxin levels by passive hemagglutination tests using fresh and formalinized sheep erythrocytes.

Authors:  H D Hochstein; J C Feeley; S H Richardson
Journal:  Proc Soc Exp Biol Med       Date:  1970-01

6.  Neutralization of the vascular permeability factor of Vibrio Cholerae in man.

Authors:  A R Martin; T M Vernon; W H Mosley
Journal:  Am J Trop Med Hyg       Date:  1969-03       Impact factor: 2.345

7.  The titration of cholera toxin and antitoxin in the rabbit ileal loop.

Authors:  G J Kasai; W Burrows
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

8.  Preparation of the vascular permeability factor of Vibrio cholerae.

Authors:  J P Craig
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

9.  In vitro detection of antibody to cholera enterotoxin in cholera patients and laboratory animals.

Authors:  R A Finkelstein; J W Peterson
Journal:  Infect Immun       Date:  1970-01       Impact factor: 3.441

10.  Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan.

Authors:  A S Benenson; A Saad; W H Mosley; A Ahmed
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408

  10 in total
  7 in total

1.  Antibody against Clostridium perfringens type A enterotoxin in human sera.

Authors:  T Uemura; C Genigeorgis; H P Riemann; C E Franti
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

2.  Suppression of the intestinal immune response to cholera toxin by specific serum antibody.

Authors:  N F Pierce
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

3.  Live oral cholera vaccine: evaluation of the clinical effectiveness of two strains in humans.

Authors:  R A Cash; S I Music; J P Libonati; A R Schwartz; R B Hornick
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

4.  Experimental Cholera in Chinchillas: the Immune Response in Serum and Intestinal Secretions to Vibrio cholerae and Cholera Toxin.

Authors:  U Blachman; S R Graboff; G E Haag; E Gottfeld; M J Pickett
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

5.  Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.

Authors:  C R Young; M M Levine; J P Craig; R Robins-Browne
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

6.  Cholera toxoid boosts serum Escherichia coli antitoxin in humans.

Authors:  D R Nalin; A al-Mahmud; G Curlin; A Ahmed; J Peterson
Journal:  Infect Immun       Date:  1974-10       Impact factor: 3.441

7.  Cellular kinetics of the intestinal immune response to cholera toxoid in rats.

Authors:  N F Pierce; J L Gowans
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.